DART

Razelle Kurzrock: Once Again, DART Hits A Target

Razelle Kurzrock, Founding Director at Michels Rare Cancers Research Laboratories, posted on X:

“Once again, DART hits a target.”

Razelle Kurzrock: Once Again, DART Hits A Target

Title: SWOG/NCI Phase II Dual Anti-CTLA-4/PD-1 Blockade in Rare Tumors (DART): Non-Epithelial Ovarian Cancer

Journal: Clinical Cancer Research, AACR

Authors: Young Kwang Chae, Megan Othus, Sandip Pravin Patel, Kelly J Wilkinson, Emily M Whitman-Purves, Jayanthi Lea, John M Schallenkamp, Nabil Adra, Leonard J Appleman, Mitchell Alden, Jessica Thomes Pepin, John A Ellerton, Andrew Poklepovic, Adam Walter, Murtuza M Rampurwala, William R Robinson, Hye Sung Kim, Liam Il-Young Chung, Christine M McLeod, Gabby Lopez, Helen X Chen, Elad Sharon, Howard Streicher, Christopher W Ryan, Charles D Blanke, Razelle Kurzrock

Read the full article.

DART

Also read OncoDaily’s special article “Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine“.

DART

AACR Adam Walter Andrew Poklepovic Anti-CTLA-4/PD-1 cancer Charles D Blanke Christine M. McLeod Christopher W Ryan Clinical Cancer Research DART Elad Sharon Emily M. Whitman-Purves Gabby Lopez Helen X Chen Howard Streicher Hye Sung Kim Jayanthi Lea Jessica Thomes Pepin John A. Ellerton John M. Schallenkamp Kelly J. Wilkinson Leonard J. Appleman Liam IL-Young Chung Megan Othus Michels Rare Cancers Research Laboratories Mitchell Alden Murtuza M. Rampurwala Nabil Adra NCI Non-Epithelial Ovarian Cancer OncoDaily Oncology Ovarian Cancer Rare Tumors Razelle Kurzrock Sandip Pravin Patel SWOG William R. Robinson Young Kwang Chae